::Artisan Pharma:: Management






Jeffrey D. Wager, MD President and Chief Executive Officer John A. Rocha, Director of Finance Nita U. Patel, PhD Senior Vice President, Regulatory Affairs & Quality Compliance Michael F. Jarvis Vice President Project Management Hajimu Sakamoto Vice President, Business Development Management Artisan has assembled a core group of senior managers focused on the clinical development of drugs in the field of critical care and hospital-based therapeutics. We intend to announce additional senior and supportive hires in the near future. Hajimu Sakamoto Vice President, Business Development Mr. Sakamoto joined Asahi Kasei Pharma Corporation (formerly Asahi Chemical Industry Co., Ltd.) in 1978 where he first was a researcher in Asahi’s research laboratories. During this period, he developed biotechnology-derived products such as tissue plasminogen activator, tumor necrosis factor, and thrombomodulin. Mr. Sakamoto was also a member of an Expert Working Group of the ICH (International Conference on Harmonization) representing the Japan Pharmaceutical Manufacturers Association and worked for establishing ICH guidelines relating to biotechnology quality issues. He then moved to Licensing and Business Development of Asahi Kasei Pharma Corporation in 1994 where he was responsible for many deals with pharmaceutical companies, including those with GSK, Shering A.G., and Novartis. Most recently, he was the general manager of Licensing and Business Development. Mr. Sakamoto has a master degree in biochemistry and biophysics from Osaka University.

Home Profile Management Board of Directors Art 123 Advisory Board Investors/Partners

Management

Artisan has assembled a core group of senior managers focused on the clinical development of drugs in the field of critical care and hospital-based therapeutics. We intend to announce additional senior and supportive hires in the near future.